Benefits Blast

A recent IRS ruling (PLR 132576-18) issued to 23andMe, Inc., has clarified that certain genetic testing services may constitute medical care for purposes of Section 213(d) of the Internal Revenue Code (the Code). This means that expenses for qualified genetic testing services can be submitted for reimbursement to health care flexible spending accounts and health savings accounts or deducted as expenses paid for medical care subject to IRS limits.